Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis
Ha Thi Nguyen†
ab,
Vishnu Nayak Badavathc,
Siddhartha Majid,
Haritha Polimatie,
Emmanuel Okellof,
Richard A. Bunced,
Nguyen Huy Thuanab,
Wan Mohd Nuzul Hakimi Wan Sallehg and
Vinay Bharadwaj Tatipamula*ab
aCenter for Pharmaceutical Biotechnology, Duy Tan University, Da Nang 550000, Vietnam
bInstitute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam. E-mail: vinaybharadwajtatipamula@duytan.edu.vn
cSchool of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Deemed-to-be-University, Green Industrial Park, TSIIC, Jadcherla, Hyderabad 509301, India
dDepartment of Chemistry, Oklahoma State University, Stillwater 74078, Oklahoma, USA
ePharmacology Department, AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India
fVeterinary Medicine Teaching and Research Center, School of Veterinary Medicine, University of California, Davis, Tulare, CA, USA
gDepartment of Chemistry, Faculty of Science and Mathematics, Universiti Pendidikan Sultan Idris, Tanjong Malim, 35900, Perak, Malaysia
First published on 2nd March 2026
Abstract
Correction for ‘Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis’ by Ha Thi Nguyen et al., RSC Adv., 2026, 16, 8960–8970, https://doi.org/10.1039/D5RA05774D.
The authors regret that several errors were introduced into the affiliations section of the published manuscript. The corrected affiliations are as shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † Current address: Department of Neurology, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. |
| This journal is © The Royal Society of Chemistry 2026 |